Drug Channels Archive for November, 2016

Click a link below to view the mailing archive as if it had been sent to you.

2016-11-30 07:49Drug Channels - CVS Changes Direction With Surprise OptumRx Deal
2016-11-29 06:46Drug Channels - Drug Channels News Roundup, November 2016: CVS Caremark, Generic Drugs, Health-System Pharmacies, and the FDA
2016-11-28 07:47Drug Channels - Expanded Access Programs 2017
2016-11-21 07:47Drug Channels - CBI’s 12th Life Sciences Trade and Channel Strategies
2016-11-17 07:56Drug Channels - A Post-Election Projection: The 2025 Payer Market for Prescription Drugs
2016-11-15 07:37Drug Channels - Genentech’s Shocking $2 Billion 340B Revelation
2016-11-14 07:50Drug Channels - Specialty Therapies 2017
2016-11-11 07:44Drug Channels - Will President Trump Eliminate The DSCSA?
2016-11-10 07:54Drug Channels - CVS Drugstore Profits Suffer as Walgreens Partners
2016-11-08 07:51Drug Channels - Behind Diplomat Pharmacy’s Plunge: A Primer on DIR Fees in Medicare Part D
2016-11-07 07:36Drug Channels - Reimbursement and Contracting Conference
2016-11-04 07:51Drug Channels - An Important Correction to Yesterday’s Post
2016-11-03 07:24Drug Channels - How Payers Profit from Drug Price Inflation: The Strange Case of EpiPen and CVS Health


<< Archive IndexSubscribe >>